Physician profile
Ryan G Porter
NPI 1235387218
$9,486.51
in general payments reported to CMS, 2019-2025
19 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.46 · 2020: $23.45 · 2021: $50.03 · 2022: $8,412 · 2023: $315 · 2024: $424 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,382.80 | 2022-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $290.42 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $133.11 | 2022-2025 | Nexplanon |
| Monaghan Medical Corporation | $95.18 | 2023-2024 | Aerochamber, Aerobika |
| Biogen, INC. | $80.06 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $71.05 | 2023 | Truclear |
| Exeltis, USA INC. | $70.31 | 2023-2025 | Slynd |
| Coopersurgical, INC. | $57.24 | 2020-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $47.81 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Pfizer INC. | $46.19 | 2023-2025 | |
| Becton, Dickinson and Company | $38.64 | 2021 | |
| Northgate Technologies, INC. | $38.31 | 2024 | Nti Branded Other |
| Sumitomo Pharma America, INC. | $30.79 | 2024 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $25.46 | 2019 | |
| Solventum Corporation | $19.85 | 2025 | Prevena |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $17.29 | 2024 | |
| Ethicon US, LLC | $16.20 | 2025 | Enseal |
| Mayne Pharma Commercial LLC | $13.64 | 2023 | |
| Abbvie INC. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.